Having trouble accessing articles? Reset your cache.

Reata rises on renal interest from Amgen

Reata gained $24.75 (13%) to $218.79 Friday, adding about $750 million in market cap, after Amgen expressed

Read the full 175 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE